In a statement, Scott Brunner, CEO of the Alliance for Pharmacy Compounding, questioned whether the FDA's resolution of the shortage had taken into account demand for the compounded drug and "the number of patients wholl need to be transitioned from a compounded version to a FDA-approved version. "Thats likely hundreds of thousands of patients," Brunner said
Besides, different extracellular mediators acting via G protein-coupled receptors (GPCRs) such as incretins, adrenergic, and muscarinic agonists, as well as signals from nutrient receptors, converge on the -cell to finely modulate insulin release [2,3,4,5]
Bissinger R, Nemkov T, DAlessandro A, Grau M, Dietz T, Bohnert BN, et al
And they point the way to a new class of antidepressants that could be freer of side effects and faster-acting than those in use today, and that may help patients for whom existing treatments don't work or have stopped working
10.1038/nature01511 2 AebersoldR.MannM